Application Sponsors
ANDA 211023 | WES PHARMA INC | |
Marketing Status
Application Products
001 | SOLUTION;ORAL | 325MG/15ML;7.5MG/15ML | 0 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHEN; HYDROCODONE BITARTRATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-03-08 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
WES PHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 211023
[companyName] => WES PHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"HYDROCODONE BITARTRATE AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; HYDROCODONE BITARTRATE","strength":"325MG\/15ML;7.5MG\/15ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/08\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-03-08
)
)